Citigroup’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.1M | Sell |
93,999
-1,628
| -2% | -$834K | 0.02% | 684 |
|
|
2025
Q4 | $53.7M | Sell |
95,627
-1,019
| -1% | -$578K | 0.02% | 611 |
|
|
2025
Q3 | $49.7M | Sell |
96,646
-2,390
| -2% | -$1.04M | 0.02% | 635 |
|
|
2025
Q2 | $31.1M | Buy |
99,036
+87,515
| +760% | +$26.3M | 0.02% | 760 |
|
|
2025
Q1 | $3.51M | Sell |
11,521
-4,349
| -27% | -$1.46M | ﹤0.01% | 2231 |
|
|
2024
Q4 | $5.27M | Sell |
15,870
-2,979
| -16% | -$1.01M | ﹤0.01% | 1900 |
|
|
2024
Q3 | $6.29M | Sell |
18,849
-3,186
| -14% | -$1.21M | ﹤0.01% | 1658 |
|
|
2024
Q2 | $9.08M | Buy |
22,035
+4,669
| +27% | +$1.85M | 0.01% | 1304 |
|
|
2024
Q1 | $7.02M | Buy |
17,366
+6,123
| +54% | +$2.15M | ﹤0.01% | 1485 |
|
|
2023
Q4 | $3.45M | Buy |
11,243
+3,717
| +49% | +$1M | ﹤0.01% | 1844 |
|
|
2023
Q3 | $1.82M | Sell |
7,526
-5,723
| -43% | -$1.46M | ﹤0.01% | 2060 |
|
|
2023
Q2 | $3.18M | Buy |
13,249
+6,995
| +112% | +$1.45M | ﹤0.01% | 1812 |
|
|
2023
Q1 | $1.18M | Buy |
6,254
+456
| +8% | +$94.3K | ﹤0.01% | 2416 |
|
|
2022
Q4 | $1.23M | Sell |
5,798
-2,462
| -30% | -$492K | ﹤0.01% | 2433 |
|
|
2022
Q3 | $1.3M | Buy |
8,260
+2,456
| +42% | +$392K | ﹤0.01% | 2500 |
|
|
2022
Q2 | $868K | Buy |
5,804
+2,519
| +77% | +$365K | ﹤0.01% | 2780 |
|
|
2022
Q1 | $537K | Sell |
3,285
-7,610
| -70% | -$1.25M | ﹤0.01% | 3457 |
|
|
2021
Q4 | $2.37M | Sell |
10,895
-36,405
| -77% | -$7.62M | ﹤0.01% | 2480 |
|
|
2021
Q3 | $8.95M | Buy |
47,300
+35,186
| +290% | +$6.42M | 0.01% | 1479 |
|
|
2021
Q2 | $2.14M | Buy |
12,114
+7,739
| +177% | +$1.34M | ﹤0.01% | 2616 |
|
|
2021
Q1 | $718K | Sell |
4,375
-21,836
| -83% | -$3.34M | ﹤0.01% | 3214 |
|
|
2020
Q4 | $3.65M | Buy |
26,211
+8,720
| +50% | +$1.1M | ﹤0.01% | 2321 |
|
|
2020
Q3 | $1.96M | Sell |
17,491
-17,196
| -50% | -$1.99M | ﹤0.01% | 2668 |
|
|
2020
Q2 | $3.23M | Buy |
34,687
+8,447
| +32% | +$719K | ﹤0.01% | 2286 |
|
|
2020
Q1 | $1.93M | Sell |
26,240
-1,248
| -5% | -$108K | ﹤0.01% | 2516 |
|
|
2019
Q4 | $2.31M | Buy |
27,488
+9,921
| +56% | +$768K | ﹤0.01% | 2825 |
|
|
2019
Q3 | $1.48M | Buy |
17,567
+2,399
| +16% | +$181K | ﹤0.01% | 3198 |
|
|
2019
Q2 | $992K | Sell |
15,168
-26,273
| -63% | -$1.51M | ﹤0.01% | 3637 |
|
|
2019
Q1 | $2.44M | Sell |
41,441
-20,506
| -33% | -$1.22M | ﹤0.01% | 2461 |
|
|
2018
Q4 | $3.28M | Sell |
61,947
-4,090
| -6% | -$225K | ﹤0.01% | 2216 |
|
|
2018
Q3 | $3.96M | Buy |
66,037
+52,769
| +398% | +$2.89M | ﹤0.01% | 2099 |
|
|
2018
Q2 | $571K | Buy |
13,268
+6,872
| +107% | +$278K | ﹤0.01% | 3950 |
|
|
2018
Q1 | $224K | Buy |
6,396
+2,152
| +51% | +$78.6K | ﹤0.01% | 4850 |
|
|
2017
Q4 | $154K | Buy |
4,244
+1,370
| +48% | +$48K | ﹤0.01% | 5272 |
|
|
2017
Q3 | $92K | Buy |
2,874
+1,830
| +175% | +$55.9K | ﹤0.01% | 5636 |
|
|
2017
Q2 | $30K | Sell |
1,044
-544
| -34% | -$15.3K | ﹤0.01% | 6090 |
|
|
2017
Q1 | $48K | Sell |
1,588
-6,668
| -81% | -$215K | ﹤0.01% | 5727 |
|
|
2016
Q4 | $298K | Buy |
8,256
+7,591
| +1,142% | +$253K | ﹤0.01% | 4939 |
|
|
2016
Q3 | $20K | Buy |
+665
| New | +$19.4K | ﹤0.01% | 6212 |
|
Other funds holding MEDP
VPM
VCM
WA
Citigroup's MEDP Position: Q1 2026 in Review
Citigroup reduced its Medpace (MEDP) stake by 1.7% in Q1 2026, selling an estimated $834K and leaving 93,999 shares worth $45.1M. The position accounts for 0.02% of the portfolio, ranked #684.
Citigroup first reported a position in MEDP in Q3 2016 and has held it in 39 quarters since. The position peaked at $53.7M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Citigroup held 93,999 shares of Medpace worth $45.1M as of Q1 2026.
- Citigroup sold 1,628 Medpace shares in Q1 2026, an estimated $834K.
- Medpace made up 0.02% of Citigroup's portfolio in Q1 2026, its #684 holding.
- Citigroup first reported a position in Medpace in Q3 2016 and has held it in 39 quarters since.
- Citigroup's Medpace position peaked at $53.7M in Q4 2025.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.